Enhanced and Selective Antiproliferative Activity of Methotrexate-Functionalized-Nanocapsules to Human Breast Cancer Cells (MCF-7)
AbstractMethotrexate is a folic acid antagonist and its incorporation into nanoformulations is a promising strategy to increase the drug antiproliferative effect on human breast cancer cells by overexpressing folate receptors. To evaluate the efficiency and selectivity of nanoformulations containing methotrexate and its diethyl ester derivative, using two mechanisms of drug incorporation (encapsulation and surface functionalization) in the in vitro cellular uptake and antiproliferative activity in non-tumoral immortalized human keratinocytes (HaCaT) and in human breast carcinoma cells (MCF-7). Methotrexate and its diethyl ester derivative were incorporated into multiwall lipid-core nanocapsules with hydrodynamic diameters lower than 160 nm and higher drug incorporation efficiency. The nanoformulations were applied to semiconfluent HaCaT or MCF-7 cells. After 24 h, the nanocapsules were internalized into HaCaT and MCF-7 cells; however, no significant difference was observed between the nanoformulations in HaCaT (low expression of folate receptors), while they showed significantly higher cellular uptakes than the blank-nanoformulation in MCF-7, which was the highest uptakes observed for the drug functionalized-nanocapsules. No antiproliferative activity was observed in HaCaT culture, whereas drug-containing nanoformulations showed antiproliferative activity against MCF-7 cells. The effect was higher for drug-surface functionalized nanocapsules. In conclusion, methotrexate-functionalized-nanocapsules showed enhanced and selective antiproliferative activity to human breast cancer cells (MCF-7) being promising products for further in vivo pre-clinical evaluations. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 787 KB)
Share & Cite This Article
De Oliveira, C.P.; Büttenbender, S.L.; Prado, W.A.; Beckenkamp, A.; Asbahr, A.C.; Buffon, A.; Guterres, S.S.; Pohlmann, A.R. Enhanced and Selective Antiproliferative Activity of Methotrexate-Functionalized-Nanocapsules to Human Breast Cancer Cells (MCF-7). Nanomaterials 2018, 8, 24.
De Oliveira CP, Büttenbender SL, Prado WA, Beckenkamp A, Asbahr AC, Buffon A, Guterres SS, Pohlmann AR. Enhanced and Selective Antiproliferative Activity of Methotrexate-Functionalized-Nanocapsules to Human Breast Cancer Cells (MCF-7). Nanomaterials. 2018; 8(1):24.Chicago/Turabian Style
De Oliveira, Catiúscia P.; Büttenbender, Sabrina L.; Prado, Willian A.; Beckenkamp, Aline; Asbahr, Ana C.; Buffon, Andréia; Guterres, Silvia S.; Pohlmann, Adriana R. 2018. "Enhanced and Selective Antiproliferative Activity of Methotrexate-Functionalized-Nanocapsules to Human Breast Cancer Cells (MCF-7)." Nanomaterials 8, no. 1: 24.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.